Next Article in Journal
Insulin Glargine Biosimilar Prescribing and Cost Trends in the United Kingdom’s Primary Care from 2020 to 2024
Previous Article in Journal
Real-World Evidence Assessing the Safety of Administering Intravenous Rituximab Biosimilar in the First Cycle and Subcutaneous Rituximab in Subsequent Cycles in B-Cell Lymphoma Patients
 
 
Article

Article Versions Notes

Action Date Notes Link
article xml file uploaded 13 June 2025 13:31 CEST Original file -
article xml uploaded. 13 June 2025 13:31 CEST Update -
article pdf uploaded. 13 June 2025 13:31 CEST Version of Record https://www.mdpi.com/2226-4787/13/3/84/pdf-vor
article html file updated 13 June 2025 13:34 CEST Original file -
article html file updated 25 June 2025 09:31 CEST Update -
article pdf uploaded. 16 July 2025 12:39 CEST Minor correction https://www.mdpi.com/2226-4787/13/3/84/pdf
article xml uploaded. 16 July 2025 12:39 CEST Minor correction https://www.mdpi.com/2226-4787/13/3/84/xml
article html file updated 16 July 2025 12:41 CEST Update -
article html file updated 29 July 2025 13:22 CEST Update https://www.mdpi.com/2226-4787/13/3/84/html
Back to TopTop